Revenue: The sum of all revenue fields included for a company's operating activities.
Ayala Pharmaceuticals, Inc. (ADXS) had Revenue of $0.01M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$0.01M |
$-48.07M |
|
$0.01M |
|
-- |
|
$36.28M |
|
$-36.27M |
|
$-15.72M |
|
$-51.98M |
|
$-51.98M |
|
$-48.07M |
|
$-48.07M |
|
$-48.07M |
|
$-48.07M |
|
$-36.27M |
|
$-35.90M |
|
6.02M |
|
6.02M |
|
$-7.99 |
|
$-7.99 |
|
| Balance Sheet Financials | |
$7.53M |
|
$0.54M |
|
$9.05M |
|
$16.58M |
|
$25.02M |
|
$8.14M |
|
$15.98M |
|
$41.00M |
|
$-24.42M |
|
$-32.81M |
|
$-24.42M |
|
11.86M |
|
| Cash Flow Statement Financials | |
$-29.48M |
|
$5.95M |
|
$26.00M |
|
$2.72M |
|
$5.21M |
|
$2.49M |
|
$1.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.30 |
|
-- |
|
-- |
|
-0.50 |
|
-0.33 |
|
-- |
|
-278969.20% |
|
-278969.20% |
|
-276130.80% |
|
-399876.90% |
|
-369784.60% |
|
$-25.48M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
196.88% |
|
146.49% |
|
-289.96% |
|
295.36% |
|
$-2.06 |
|
$-4.23 |
|
$-4.90 |
|